• 1
    Carmona L, Ballina J, Gabriel R et al. The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis 2001; 60: 10405.
  • 2
    White K, Speechley M, Harth M et al. The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 1999; 26: 1928.
  • 3
    Wolfe F, Ross K, Anderson J et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 1928.
  • 4
    Wolfe F. The epidemiology of fibromyalgia. J Musculoskelet Pain 1993; 1: 13748.
  • 5
    Wolfe F, Smythe HA, Yunus MB et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990; 33: 16072.
  • 6
    Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 2005; 23 (Suppl. 39): S154S62.
  • 7
    Bennett RM. Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia. Mayo Clin Proc 1999; 19: 38598.
  • 8
    Staud R, Domingo M. Evidence for abnormal pain processing in fibromyalgia syndrome. Pain Med 2001; 2: 20815.
  • 9
    Bennett RM, Schein J, Kosinski MR et al. Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen. Arthritis Rheum 2005; 53: 51927.
  • 10
    Ware JE, Snow KK, Kosinski M et al. SF-36 Health Survey: Manual and Interpretation Guide. Lincoln, RI: QualityMetric Incorporated 1993, 2000.
  • 11
    Ware JE, Kosinski M, Keller SD. A 12-item short form health survey (SF-12): construction of scales and preliminary tests of reliability and validity. Med Care 1996; 32: 22033.
  • 12
    Wolfe F, Michaud K. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize RA patients with fibromyalgia. J Rheumatol 2004; 31: 695700.
  • 13
    Faull K. A pilot study of the comparative effectiveness of two water-based treatments for fibromyalgia syndrome: watsu and aix massage. J Bodywork Mov Therap 2005; 9: 20210.
  • 14
    Picavet HS, Hoeymans N. Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study. Ann Rheum Dis 2004; 63: 7239.
  • 15
    Schlenk EA, Erlen JA, Dunbar-Jacob J et al. Health-related quality of life in chronic disorders: a comparison across studies using the MOS SF-36. Qual Life Res 1998; 7: 5765.
  • 16
    DaCosta D, Dobkin PL, Fitzcharles M-A et al. Determinants of health status in fibromyalgia: a comparative study with systematic lupus erythematosus. J Rheumatol 2000; 27: 36572.
  • 17
    Bergman S. Psychosocial aspects of chronic widespread pain and fibromyalgia. Disabil Rehabil 2005; 27: 67583.
  • 18
    Neumann L, Berzak A, Buskila D. Measuring health status in Israeli patients with fibromyalgia syndrome and widespread pain and healthy individuals: utility of the Short Form 36-item (SF-36). Semin Arthritis Rheum 2000; 29: 4008.
  • 19
    Altman R, Asch E, Bloch D et al. Development of the criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 1986; 29: 103949.
  • 20
    Turk D, Melzack R, eds. Handbook of Pain Assessment. New York: The Guilford Press, 1992.
  • 21
    MacGregor AJ, Ollier WPR, Silman AJ. Modification of ACR classification criteria for rheumatoid arthritis for use in population studies. Br J Rheumatol 1992; 21 (Suppl.): 37.
  • 22
    Altman R, Alarcon G, Appelrouth D et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 1990; 33: 160110.
  • 23
    Manthorpe R, Oxholm P, Prause JU et al. The Copenhagen criteria for Sjogren's syndrome. Scand J Rheumatol 1986; 15 (Suppl.): 1921.
  • 24
    Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 25
    Headache Classification Committee of the International Headache Society. The international classification of headache disorders, 2nd edition. Cephalalgia 2004; 24 (Suppl. 1): 1160.
  • 26
    Tam EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 12717.
  • 27
    Van der Zee K, Sanderman R. Het meten van de algemene gezondheidstoestand met de RAND-36: een handleiding. Groningen: Noordelijk Centrum voor Gezondheidsvraagstukken, Rijksuniversiteit Groningen, 1993.
  • 28
    Lewin-Epstein N, Sagiv-Schifter T, Shabtai E, Shmueli A. Validation of the SF 36-item short-form health survey (Hebrew version) in the adult population of Israel. Med Care 1998; 36: 136170.
  • 29
    Ciconelli R. Portuguese version and validation of the generic assessment questionnaire on quality of life ‘Medical outcomes study 36-item short form health survey’ (SF-36). PhD thesis. Sao Paulo: Unifesp, 1997: 143.
  • 30
    Gandek B, Ware J, Aaronson N et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA project. J Clin Epidemiol 1998; 51: 11718.
  • 31
    Sullivan M, Karlsson R, Ware J. SF-36 Health survey – Swedish Manual and Interpretation Guide. Göterborg: Sahlgrenska University Hospital, 1994.
  • 32
    Strömbeck B, Ekdahl C, Manthorpe R et al. Health-related quality of life in primary Sjogren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol 2000; 29: 208.
  • 33
    Walker EA, Keegan D, Gardner G et al. Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: psychiatric diagnoses and functional disability. Psychosom Med 1997; 59: 56571.
  • 34
    Tüzün EH, Albayrak G, Eker L et al. A comparison study of quality of life in women with fibromyalgia and myofacial pain syndrome. Disabil Rehabil 2004; 26: 198202.
  • 35
    Baraniuk JN, Whalen G, Cunningham J et al. Cerebral fluid levels of opioid peptides in fibromyalgia and chronic low back pain. BMC Musculoskelet Disord 2004; 5: 17.
  • 36
    Escalante A, Fischbach M. Musculoskeletal manifestations, pain, and quality of life in Persian Gulf War veterans referred for rheumatologic evaluation. J Rheumatol 1998; 25: 222835.
  • 37
    Bennett RM, Kamin M, Karim R et al. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med 2003; 114: 53745.
  • 38
    Arnold LM, Lu Y, Crofford LJ et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004; 50: 297484.
  • 39
    Crofford LJ, Rowbotham MC, Mease PJ et al. Pregabalin for the treatment of fibromyalgia syndrome. Arthritis Rheum 2005; 52: 126473.
  • 40
    Ifergane G, Buskila D, Simiseshvely N et al. Prevalence of fibromyalgia syndrome in migraine patients. Cephalalgia 2005; 26: 4516.
  • 41
    Alarcon GS, McGwin G, Uribe A et al. Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). xvii. predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum 2004; 51: 46574.
  • 42
    Tang S, Calkins H, Petri M. Neurally mediated hypotension in systemic lupus erythematosus patients with fibromyalgia. Rheumatology (Oxford) 2004; 43: 60914.
  • 43
    Marcus DA, Bernstein C, Rudy TE. Fibromyalgia and headache: an epidemiological study supporting migraine as part of the fibromyalgia syndrome. Clin Rheumatol 2005; 24: 595601.
  • 44
    Acquardo C, Berzon R, Dubois D et al. Incorporating the patient's perspective into drug development and communication: An ad hoc task force report of the patient-reported outcomes (PRO) harmonization group meeting at the Food and Drug Administration, February 16, 2001. Value Health 2003; 6: 55230.
  • 45
    Pagano T, Matsutani L, Ferreira EAG et al. Assessment of anxiety and quality of life in fibromyalgia patients. Sao Paulo Med J 2004; 122: 2528.
  • 46
    Ulaş UH, Unlu E, Hammamcioglu K et al. Dysautonomia in fibromyalgia syndrome: sympathetic skin responses and RR Interval analysis. Rheumatol Int 2005; 26: 3837.
  • 47
    Alanoğlu E, Ulaş U, Özdağ F et al. Auditory event-related brain potentials in fibromyalgia syndrome. Rheumatol Int 2004; 25: 3459.
  • 48
    Martinez JE, Filho ISB, Kubokawa K et al. Evaluation of the quality of life in Brazilian women with fibromyalgia, through the medical outcome survey 36 item short-form study. Disabil Rehabil 2001; 32: 648.
  • 49
    Raj SR, Brouillard D, Simpson CS et al. Dysautonomia among patients with fibromyalgia: a noninvasive assessment. J Rheumatol 2000; 27: 26605.
  • 50
    Reisine S, Fifield J, Walsh S et al. Employment and quality of life outcomes among women with fibromyalgia compared to healthy controls. Women Health 2004; 39: 119.
  • 51
    Buskila D, Neumann L, Alhoashle A et al. Fibromyalgia syndrome in men. Semin Arthritis Rheum 2000; 30: 4751.
  • 52
    Assis MR, Silva LE, Alves AMB et al. A randomized controlled trial of deep water running: clinical effectiveness of aquatic exercise to treat fibromyalgia. Arthritis Rheum 2006; 55: 5765.
  • 53
    Donaldson MS, Speight N, Loomis S. Fibromyalgia syndrome improved using a mostly raw vegetarian diet: an observational study. BMC Complement Altern Med 2001; 1: 17.
  • 54
    Fregni F, Gimenes R, Valle AC et al. A randomized, sham-controlled, proof of principle study of transcranial direct current stimulation for the treatment of pain in fibromyalgia. Arthritis Rheum 2006; 54: 398898.
  • 55
    Mannerkorpi K, Ahlmen M, Ekdahl C. Six- and 24-month follow-up of pool exercise therapy and education for patients with fibromyalgia. Scand J Rheumatol 2002; 31: 30610.
  • 56
    Neumann L, Sukenik S, Bolotin A et al. The effect of balneotherapy at the Dead Sea on the quality of life of patients with fibromyalgia syndrome. Clin Rheumatol 2001; 20: 159.
  • 57
    Valim V, Oliveira L, Suda A et al. Aerobic fitness effects in fibromyalgia. J Rheumatol 2003; 30: 10609.
  • 58
    Vitorino D, Carvalho L, Prado G. Hydrotherapy and conventional physiotherapy improve total sleep time and quality of life of fibromyalgia patients: randomized clinical trial. Sleep Med 2006; 7: 2936.
  • 59
    Zijlstra TR, Van De Laar MAFJ, Bernelot Moens HJ et al. Spa treatment for primary fibromyalgia syndrome: a combination of thalassotherapy, exercise and patient education improves symptoms and quality of life. Rheumatology (Oxford) 2005; 44: 53946.
  • 60
    Hidalgo J, Rico-Villademoros F, Calandre EP. An open-label study of quetiapine in the treatment of fibromyalgia. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 717.